BCM
LLY icon

Blume Capital Management’s Eli Lilly LLY Stock Holding History

Blume Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72K Hold
60
– – 0.01% 180
2026
Q1 		$55.2K Sell
60
-22
-27% -$22.3K 0.01% 191
2025
Q4 		$88.1K Sell
82
-6
-7% -$5.74K 0.02% 154
2025
Q3 		$67.1K Buy
88
+44
+100% +$32.7K 0.01% 174
2025
Q2 		$34.3K Buy
44
+14
+47% +$10.9K 0.01% 205
2025
Q1 		$24.8K Buy
30
+5
+20% +$4.16K 0.01% 218
2024
Q4 		$19.3K Sell
25
-15
-38% -$12.4K ﹤0.01% 228
2024
Q3 		$35.4K Buy
40
+15
+60% +$13.5K 0.01% 208
2024
Q2 		$22.6K Hold
25
– – 0.01% 219
2024
Q1 		$19.4K Hold
25
– – ﹤0.01% 222
2023
Q4 		$14.6K Hold
25
– – ﹤0.01% 231
2023
Q3 		$13.4K Sell
25
-9
-26% -$4.64K ﹤0.01% 234
2023
Q2 		$15.9K Hold
34
– – ﹤0.01% 225
2023
Q1 		$11.7K Hold
34
– – ﹤0.01% 237
2022
Q4 		$12.4K Hold
34
– – ﹤0.01% 239
2022
Q3 		$11K Buy
+34
New +$10.8K ﹤0.01% 237

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Blume Capital Management's LLY Position: Q2 2026 in Review

Blume Capital Management held its Eli Lilly (LLY) position steady in Q2 2026 at 60 shares worth $72K. The position accounts for 0.01% of the portfolio, ranked #180.

Blume Capital Management first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. The position peaked at $88.1K in Q4 2025. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Blume Capital Management held 60 shares of Eli Lilly worth $72K as of Q2 2026.
  • Blume Capital Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.01% of Blume Capital Management's portfolio in Q2 2026, its #180 holding.
  • Blume Capital Management first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
  • Blume Capital Management's Eli Lilly position peaked at $88.1K in Q4 2025.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.